SCHEDULE 13G/A: T. Rowe Price Investment Management Discloses 1.0% Passive Stake in Acadia Healthcare

T. Rowe Price Investment Management, Inc. has filed an amended Schedule 13G, disclosing a 1.0% beneficial ownership stake in Acadia Healthcare Company Inc. as of March 31, 2025.

Summary

• T. Rowe Price Investment Management, Inc. filed an Amendment No. 4 to Schedule 13G regarding its beneficial ownership in ACADIA HEALTHCARE CO INC.
• The filing indicates that T. Rowe Price Investment Management, Inc. beneficially owns 949,569 shares of ACADIA HEALTHCARE CO INC common stock.
• This ownership represents 1.0% of the class of securities.
• T. Rowe Price Investment Management, Inc. holds sole voting power over 946,348 shares and sole dispositive power over 949,569 shares.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual, regulatory disclosure of beneficial ownership and does not contain information that would indicate a positive or negative sentiment regarding the company's performance or outlook.

Future Outlook

This document is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance regarding the issuer's future outlook.

Industry Context

This filing is a standard disclosure of a passive investment stake by a major asset manager in a publicly traded healthcare company. It does not provide specific insights into broader industry trends or competitive positioning beyond the fact that a significant institutional investor holds a position in Acadia Healthcare.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant passive ownership stake held by a major institutional investor, T. Rowe Price Investment Management, Inc.

Key Dates

Keywords

Acadia Healthcare, T. Rowe Price, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management, SEC Filing, Healthcare Services